The results from the ROC analysis on serum GDF15 concentrations measured with the ELISA kit and the LTIA device in 35 patients with MDs, neurodegenerative controls, and healthy controls are shown in Figure 3A,B, respectively. Here, GDF15 is linked to myelodysplastic syndrome.